Cargando…
Resolved HBV behavior during the treatment of chronic HCV infection with direct-acting antivirals
AIM: This paper aimed to assess and follow up the course of resolved HBV (hepatitis B virus) during and after treatment with direct-acting antiviral drugs (DAAs). BACKGROUND: Co-infection with hepatitis B and hepatitis C is increasingly recognized in patients with chronic hepatitis. Resolved HBV in...
Autores principales: | Mohamed, Salem Y., Gaballah, Baasim A., Mohamed Elsadek, Hany, Hassan Emara, Mohamed, Hamed, Emad F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820844/ https://www.ncbi.nlm.nih.gov/pubmed/31749918 |
Ejemplares similares
-
The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients
por: Tseng, Chih-Wei, et al.
Publicado: (2022) -
Changes in portal blood flow and liver functions in cirrhotics during Ramadan fasting in the summer; a pilot study
por: Mohamed, Salem Y, et al.
Publicado: (2016) -
Prospective Comparison of Hepatocellular Carcinoma Behavior and Survival of Patients who Did or Did not Receive HCV Direct-Acting Antivirals
por: El-Kassas, Mohamed, et al.
Publicado: (2023) -
HIV/HCV Antiviral Drug Interactions in the Era of Direct-acting Antivirals
por: Rice, Donald P., et al.
Publicado: (2016) -
Differential expression of long noncoding RNA in hepatocellular carcinoma on top of chronic HCV and HBV infections
por: Sabry, Hany S., et al.
Publicado: (2021)